Tacrolimus Decreases Glucocorticoid Use in Refractory Myositis-Associated Interstitial Lung Disease
Factors associated with favorable treatment responses to conventional therapy and tacrolimus in myositis-associated interstitial lung disease were examined in a retrospective cohort study.